Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/KRYSTAL-BIOTECH-INC-37797982/news/Krystal-Biotech-gibt-die-Validierung-des-Zulassungsantrags-fur-Vyjuvek-zur-Behandlung-von-dystrophe-45443660/?utm_source=whatsapp&utm_medium=social&utm_campaign=share